Julian Bailes
Hoofd Techniek/Wetenschap/O&O bij BLUE WATER VENTURES INTERNATIONAL, INC.
Profiel
Julian Bailes currently works at Psycheceutical Bioscience, Inc., as Director & Chief Medical Officer and Psycheceutical, Inc., as Director & Chief Medical Officer from 2023.
Actieve functies van Julian Bailes
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Hoofd Techniek/Wetenschap/O&O | 10-01-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
